Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

AgeChem Venture Fund

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 16
Average round size
info
The average size of a deal this fund participated in
$19M
Portfolio companies 11
Rounds per year 0.94
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.31
Exits 5
Key employees 3
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Therapeutics
  • Health Care
  • Biopharma
  • Pharmaceutical
Summary

The main office of represented VC is situated in the Montru00e9al. The fund was located in North America if to be more exact in Canada.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Aerpio Pharmaceuticals, Sorbent Therapeutics, Alethia BioTherapeutics. We can highlight the next thriving fund investment areas, such as Therapeutics, Medical.

Besides them, we counted 3 critical employees of this fund in our database.

The important activity for fund was in 2011. Considering the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The higher amount of exits for fund were in 2018. Deals in the range of 10 - 50 millions dollars are the general things for fund. Opposing the other organizations, this AgeChem Venture Fund works on 4 percentage points more the average amount of lead investments.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the AgeChem Venture Fund, startups are often financed by Venture Investors, Sofinnova Investments, Novartis Venture Fund. The meaningful sponsors for the fund in investment in the same round are Novartis Venture Fund, Venture Investors, Triathlon Medical Venture Partners. In the next rounds fund is usually obtained by Novartis Venture Fund, Venture Investors, Triathlon Medical Venture Partners.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of AgeChem Venture Fund:
Typical Co-investors
AgeChem Venture Fund is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after AgeChem Venture Fund:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Canada
Funds with similar focus located in Canada:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
21st Century Fox New York, New York, United States
Antipodean Adventures California, Los Angeles, United States
Babson Capital Management New York, New York, United States
Conway Foundation Arkansas, Conway, United States
Gambit Ventures New York, New York, United States
Haselmeier Baden-Wurttemberg, Germany, Stuttgart
InvAscent Mauritius, Port Louis, Port Louis
Normandy Ventures New Jersey, Skillman, United States
Pioneers Ventures Austria, Linz, Oberosterreich
QBE Insurance Group Australia, New South Wales, Sydney
Rolesis Holdings -
SGPA France, Ile-de-France, Neuilly-sur-seine
ThirdRock Group -
Uni.Fund Athens, Attiki, Greece
Ward Ferry Management China, Hong Kong, Hong Kong Island
Ziffren Brittenham California, Los Angeles, United States
ZJU Joint Innovation Investment China, Hangzhou, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Aerpio Pharmaceuticals

Biotechnology
Health Care
Therapeutics
$36M06 Nov 2013 Cincinnati, Ohio, United States

Akebia Therapeutics

Biotechnology
Health Care
Therapeutics
$41M04 Jun 2013 Cambridge, Massachusetts, United States

Biotechnology
Health Care
Therapeutics
$4M02 Nov 2012 Quebec

Sorbent Therapeutics

Biopharma
Biotechnology
Pharmaceutical
$36M30 Jun 2011 Sunnyvale, California, United States

Akebia Therapeutics

Biotechnology
Health Care
Therapeutics
$22M26 Apr 2011 Cambridge, Massachusetts, United States

Conatus Pharmaceuticals

Biotechnology
Health Care
Therapeutics
$20M11 Feb 2011 San Diego, California, United States

Sorbent Therapeutics

Biopharma
Biotechnology
Pharmaceutical
$21M13 Sep 2010 Sunnyvale, California, United States

Alethia BioTherapeutics

Biotechnology
Health Care
Therapeutics
$9M07 Sep 2010 Quebec

Altair Therapeutics

Biopharma
Biotechnology
Therapeutics
$17M02 Feb 2010 San Diego, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent AgeChem Venture Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 16
Average round size 19M
Rounds per year 0.94
Peak activity year 2011
Lead investments 3
Follow on index 0.31
Exits 5
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Aerpio Pharmaceuticals

Biotechnology
Health Care
Therapeutics
$36M06 Nov 2013 Cincinnati, Ohio, United States

Akebia Therapeutics

Biotechnology
Health Care
Therapeutics
$41M04 Jun 2013 Cambridge, Massachusetts, United States

Biotechnology
Health Care
Therapeutics
$4M02 Nov 2012 Quebec

Sorbent Therapeutics

Biopharma
Biotechnology
Pharmaceutical
$36M30 Jun 2011 Sunnyvale, California, United States

Akebia Therapeutics

Biotechnology
Health Care
Therapeutics
$22M26 Apr 2011 Cambridge, Massachusetts, United States

Conatus Pharmaceuticals

Biotechnology
Health Care
Therapeutics
$20M11 Feb 2011 San Diego, California, United States

Sorbent Therapeutics

Biopharma
Biotechnology
Pharmaceutical
$21M13 Sep 2010 Sunnyvale, California, United States

Alethia BioTherapeutics

Biotechnology
Health Care
Therapeutics
$9M07 Sep 2010 Quebec

Altair Therapeutics

Biopharma
Biotechnology
Therapeutics
$17M02 Feb 2010 San Diego, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: